How to Import Oncology Medicines into the USA A Practical Guide
Author: Onco MedicineRegulatory Team
On August 29, 2026, regulatory teams updated patient access protocols for importing life-saving oncology medicines into the United States. Sourcing specialized cancer therapies requires a thorough understanding of FDA regulations, customs documentation, and cold-chain logistics. For patients and healthcare providers looking to secure authentic products with complete batch verification, navigating these requirements is key to avoiding customs delays and ensuring drug integrity.
At Onco Medicine, we operate a direct-to-patient Good Distribution Practice (GDP) protocol that guarantees authentic medicines, helping patients across the USA legally and safely import critical specialty drugs.
The FDA Personal Importation Policy (PIP)
The U.S. Food and Drug Administration (FDA) provides a legal pathway for individuals to import specialized medicines under its Personal Importation Policy. To qualify for this scheme, the following criteria must be met:
- Serious Conditions: The medication must be for a serious condition for which effective treatment may not be available domestically.
- No Commercialization: The imported drug must not be distributed or commercialized within the US.
- 90-Day Supply Limit: Shipments are strictly limited to a maximum of a 3-month (90-day) supply per import permit.
- US Oncologist Prescription: A valid medical prescription from a licensed US oncologist is mandatory.
Essential Sourcing & Customs Documentation
Smooth customs clearance by US Customs and Border Protection (CBP) and the FDA at ports of entry depends on document readiness. Sourcing specialty oncology drugs requires the following paperwork to be attached to the shipment:
- Physician Prescription: A copy of the signed prescription from a licensed US practitioner.
- Certificate of Analysis (COA): Official document from the manufacturer verifying the batch number, chemical composition, and safety standards of the drug.
- Detailed Commercial Invoice: Outlining the product name, manufacturer, quantity, unit price, and patient details.
- Importer’s Declaration: A statement confirming that the medicine is imported under the personal importation scheme for personal clinical use.
Cold-Chain Logistics & Biological Integrity
A significant portion of modern oncology treatments (such as monoclonal antibodies and targeted immunotherapies like Keytruda or Enhertu) are temperature-sensitive biologics. Maintaining their clinical efficacy requires strict environmental control:
- Strict Temperature Range: Products must be stored and transported within a 2°C to 8°C (36°F to 46°F) temperature range.
- Validated Medical Containers: Heavy-duty, vacuum-insulated shipping containers are used to shield the vials from environmental extremes during air transit.
- Live Data Loggers: Shipments include continuous digital temperature loggers that record the temperature profile throughout the journey, providing verification upon delivery.
Secure Professional Sourcing & Support
For inquiries regarding batch availability, legal clearance documentation, or pricing details, please reach out to our dedicated compliance desk at support@onco-medicine.com. You can also connect directly with a qualified pharmacist via our verified WhatsApp Support Line at +91 94275 19809.